• Measure Summary
  • NQMC:010522
  • 2015 Oct
  • NQF-Endorsed Measure

Comprehensive diabetes care: percentage of members 18 to 75 years of age with diabetes (type 1 and type 2) whose most recent hemoglobin A1c (HbA1c) level is less than 8.0% (controlled).

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:010540
  • 2015 Oct

Adherence to antipsychotic medications for individuals with schizophrenia: percentage of members 19 to 64 years of age during the measurement year with schizophrenia who were dispensed and remained on an antipsychotic medication for at least 80 percent of their treatment period.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:010528
  • 2015 Oct

Statin therapy for patients with diabetes: percentage of members 40 to 75 years of age during the measurement year with diabetes who do not have ASCVD who remained on a statin medication of any intensity for at least 80% of the treatment period.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:010615
  • 2015 Oct

Inpatient utilization—general hospital/acute care: summary of utilization of acute inpatient care and services in the following categories: Total Inpatient, Maternity, Surgery, and Medicine.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:010525
  • 2015 Oct
  • NQF-Endorsed Measure

Comprehensive diabetes care: percentage of members 18 to 75 years of age with diabetes (type 1 and type 2) who received medical attention for nephropathy.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:010517
  • 2015 Oct
  • NQF-Endorsed Measure

Persistence of beta-blocker treatment after a heart attack: percentage of members 18 years of age and older during the measurement year who were hospitalized and discharged from July 1 of the year prior to the measurement year to June 30 of the measurement year with a diagnosis of AMI and who received persistent beta-blocker treatment for six months after discharge.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:010511
  • 2015 Oct

Pharmacotherapy management of COPD exacerbation: percentage of COPD exacerbations for members 40 years of age and older who had an acute inpatient discharge or ED visit on or between January 1 and November 30 of the measurement year and who were dispensed a systemic corticosteroid within 14 days of the event.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:010550
  • 2015 Oct

Potentially harmful drug-disease interactions in the elderly: percentage of Medicare members 65 years of age and older who have evidence of an underlying disease, condition or health concern and who were dispensed an ambulatory prescription for a potentially harmful medication, concurrent with or after the diagnosis.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:010514
  • 2015 Oct
  • NQF-Endorsed Measure

Medication management for people with asthma: percentage of members 5 to 85 years of age during the measurement year who were identified as having persistent asthma and who were dispensed an asthma controller medication that they remained on for at least 75% of their treatment period.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:010532
  • 2015 Oct
  • NQF-Endorsed Measure

Antidepressant medication management (effective continuation phase treatment): percentage of members 18 years of age and older who were treated with antidepressant medication, had a diagnosis of major depression and who remained on an antidepressant medication for at least 180 days (6 months).

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:010619
  • 2015 Oct
  • NQF-Endorsed Measure

Plan all-cause readmissions: the number of acute inpatient stays during the measurement year that were followed by an unplanned acute readmission for any diagnosis within 30 days and the predicted probability of an acute readmission, for members 18 years of age and older.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:010530
  • 2015 Oct
  • NQF-Endorsed Measure

Osteoporosis management in women who had a fracture: percentage of women 67 to 85 years of age who suffered a fracture and who had either a bone mineral density (BMD) test or prescription for a drug to treat or prevent osteoporosis in the six months after the fracture.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:010535
  • 2015 Oct
  • NQF-Endorsed Measure

Follow-up after hospitalization for mental illness: percentage of discharges for members 6 years of age and older who were hospitalized for treatment of selected mental illness diagnoses and who had an outpatient visit, an intensive outpatient encounter, or partial hospitalization with a mental health practitioner within 30 days of discharge.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:010520
  • 2015 Oct
  • NQF-Endorsed Measure

Comprehensive diabetes care: percentage of members 18 to 75 years of age with diabetes (type 1 and type 2) who had hemoglobin A1c (HbA1c) testing.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:010613
  • 2015 Oct

Frequency of selected procedures: summary of utilization of fourteen frequently performed procedures.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:010538
  • 2015 Oct
  • NQF-Endorsed Measure

Diabetes monitoring for people with diabetes and schizophrenia: percentage of members 18 to 64 years of age with schizophrenia and diabetes who had both an LDL-C test and an HbA1c test during the measurement year.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:010523
  • 2015 Oct

Comprehensive diabetes care: percentage of members 18 to 64 years of age with diabetes (type 1 and type 2) whose most recent hemoglobin A1c (HbA1c) level is less than 7.0% (controlled).

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:010541
  • 2015 Oct

Metabolic monitoring for children and adolescents on antipsychotics: percentage of children and adolescents 1 to 17 years of age who had two or more antipsychotic prescriptions and had metabolic testing.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:010519
  • 2015 Oct

Statin therapy for patients with cardiovascular disease: percentage of males 21 to 75 years of age and females 40 to 75 years of age during the measurement year who were identified as having clinical ASCVD who remained on a high- or moderate-intensity statin medication for at least 80% of the treatment period.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:010616
  • 2015 Oct

Identification of alcohol and other drug services: summary of the number and percentage of members with an alcohol and other drug (AOD) claim who received the following chemical dependency services during the measurement year: any service, inpatient, intensive outpatient or partial hospitalization, and outpatient or ED.

National Committee for Quality Assurance